Week of December 13, 2022 | Vol. 11, Issue 48

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

JP Morgan Healthcare Conference

January 9-12, 2023 - San Francisco, CA

SCOPE Summit for Clinical Ops Executives

February 6-9, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS

Pharma & Biotech

13 transactions totaling $174 million


Supplies, Equipment & Services

19 transactions totaling $38 million


Healthcare Facilities & Distributors

11 transactions


Healthcare IT & Managed Care

4 transactions totaling $43 million

PRIVATE PLACEMENTS

Pharma & Biotech

39 transactions totaling $966 million


Supplies, Equipment & Services

22 transactions totaling $221 million


Healthcare Facilities & Distributors

4 transaction totaling $110 million


Healthcare IT & Managed Care

11 transactions

PUBLIC OFFERINGS

Pharma & Biotech

22 transactions totaling $3,456 million


Supplies, Equipment & Services

7 transactions totaling $604 million


Healthcare Facilities & Distributors

1 transaction


Healthcare IT & Managed Care

4 transactions

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider



Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio


Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO


Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

Tjoapack strengthens its Injectables offering with addition of pre-filled syringes assembly and packaging services

Tjoapack - November 30, 2022

Experic Closes $14 Million Series B Financing

Business Wire - November 30, 2022

August Bioservices Closes $65M Series B

Business Wire - December 1, 2022

Purolite Opens New Pharmaceutical Manufacturing Facility in King of Prussia

Contract Pharma - December 5, 2022

Recipharm announces extension of commercial manufacturing to support RedHill Biopharma's Talicia® to 2026

Recipharm - December 5, 2022

GSK, Sanofi, Takeda, Singapore Researchers Partner to Boost Biologics Innovation

Contract Pharma - December 6, 2022

AbbVie, HotSpot Therapeutics Enter Strategic Immunology Alliance

Contract Pharma - December 6, 2022

Catalent Opens One of the World’s Largest Commercial-Scale Cell Therapy Manufacturing Facilities at its European Center of Excellence for Cell Therapies in Gosselies, Belgium

Catalent - December 8, 2022

Vertex, Entrada Establish EEV Therapeutics Alliance for Myotonic Dystrophy

Contract Pharma - December 8, 2022

TANNER NEWS

Linkedin  

WHITEPAPER: Bridging the Gap from Pharma to Patient

How can pharma companies maintain supply continuity of their products amid fluctuating demands and unpredictable global challenges? Download our newest whitepaper examining some of the reasons behind the unavailability of medical products and how demand can be met efficiently and compliantly even in times of uncertainty.

Medicine Should Have No Borders

Most countries have a pathway for patients to get access to a medicine that isn’t available in their country or is still in clinical development. Early Access Programs are a pathway by which pharma and biopharmaceutical companies provide innovative drugs to patients with serious conditions—allowing manufacturers the opportunity to simultaneously build relationships with KOLs & physicians, collect RWE & support patients in need. Learn more.